STOCK TITAN

Pliant Therapeutics, Inc. (PLRX) Net Income by Year

PLRX

Pliant Therapeutics, Inc. reported $149.3M in net income in fiscal year 2025. This represents a decrease of 29.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Pliant Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income $149.3M
YoY -29.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PLRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income$149.3M-29.0%$210.3M+30.4%$161.3M+230.8%-$123.3M-26.8%-$97.3M-134.2%-$41.5M-6482.1%-$631K

PLRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$22.4M+48.3%-$20.0M+64.3%N/A-$26.3M+54.5%-$43.3M+22.5%-$56.2M-19.6%N/A-$57.8M-39.2%-$55.9M-35.6%-$47.0M-25.1%N/A-$41.5M-35.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Pliant Therapeutics, Inc. financials

Frequently Asked Questions

What was Pliant Therapeutics, Inc.'s net income in fiscal year 2025?

Pliant Therapeutics, Inc. reported $149.3M in net income in fiscal year 2025.

How fast is Pliant Therapeutics, Inc.'s net income growing?

Pliant Therapeutics, Inc. (PLRX) net income fell by 29.0% year over year, from $210.3M to $149.3M in fiscal year 2025.

How has Pliant Therapeutics, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Pliant Therapeutics, Inc. (PLRX) net income went from -$631K in fiscal year 2019 to $149.3M in fiscal year 2025.

Pliant Therapeutics, Inc. (PLRX) reported -$22.4M in net income in Q2 2026. This represents an increase of 48.3% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Pliant Therapeutics, Inc. (PLRX) reported on that line in every period on record.